We are live on
!
Find out more
AA
AQR Arbitrage Portfolio holdings
AUM
$6.09B
1-Year Est. Return
27.01%
This Fund
S&P 500
This Quarter
Est. Return
+11.52%
1 Year Est. Return
+27.01%
3 Year Est. Return
+77.25%
5 Year Est. Return
+160.09%
10 Year Est. Return
+1,244.43%
AUM
$2.48B
AUM Growth
+$250M
(+11%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-28.87%
Top 10 Holdings %
Top 10 Hldgs %
15.92%
Holding
859
New
65
Increased
151
Reduced
87
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$31.7M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$30.6M |
| 3 |
X
US Steel
X
|
+$29.6M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$28.6M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
+$28.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$51.3M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$36.5M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$36.3M |
| 4 |
VMW
VMware, Inc
VMW
|
+$28.1M |
| 5 |
DEN
Denbury Inc.
DEN
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.2% |
| 2 | Healthcare | 8.06% |
| 3 | Consumer Discretionary | 3.81% |
| 4 | Technology | 3.5% |
| 5 | Consumer Staples | 2.56% |
Similar funds
JWBC
GA
CIS
EMPI
HCM
HPG
DTC
AWA
AQR Arbitrage's Q4 2023 Portfolio in Review
As of Q4 2023, AQR Arbitrage held 859 positions worth $2.48B, up 11% from $2.23B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
AQR Arbitrage withdrew a net $715M in Q4 2023, closing 168 positions and reducing 87 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $51.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, AQR Arbitrage opened a new position in Hess worth $31.2M.
- AQR Arbitrage's largest Q4 2023 buy was Hess: 216,329 shares worth $31.2M.
- AQR Arbitrage added most to WestRock Company in Q4 2023, an estimated $11.8M increase.
- AQR Arbitrage's biggest Q4 2023 reduction was Screaming Eagle Acquisition Corp. Class A Ordinary Shares, cutting an estimated $14.2M.
- AQR Arbitrage fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $51.3M.
- AQR Arbitrage's ten largest holdings make up 16% of its $2.48B portfolio in Q4 2023.
- AQR Arbitrage opened 65 new positions and closed 168 in Q4 2023.
- AQR Arbitrage's portfolio value rose 11% quarter-over-quarter to $2.48B.
Based on AQR Arbitrage's 13F filing for Q4 2023, filed 14 Feb 2024.